MMP9 and apparent mineralocorticoid excess: Activated matrix metalloproteinases (particularly MMP‐2 and MMP‐9) might deteriorate myosin light chain‐1, cardiac troponin‐I (cTnI) and several other sarcomeric cytoskeletal proteins, thus causing myocardial contractile disorder related to APE.5, 6